Kymera Therapeutics Cash Flow Statement (2019-2025) | KYMR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -11.87M-11.81M-11.28M-14.22M-8.11M-12.81M-13.19M-24.76M-28.71M-34.05M-36.97M-40.85M-44.92M-38.69M-45.38M-43.43M-57.55M-19.36M-57.90M-50.99M-72.18M-80.81M-74.50M-84.67M-92.62M
Depreciation and Depletion 0.20M0.30M0.40M0.40M0.50M0.50M0.50M0.60M700.002.40M0.70M0.70M0.80M0.80M0.90M0.90M0.90M0.90M1.50M1.90M2.00M2.00M1.60M1.70M2.10M
Share-based Compensation 0.23M0.30M0.37M0.66M2.33M1.83M3.17M5.73M7.40M8.68M7.87M9.62M9.08M8.91M9.38M11.18M11.65M10.90M11.97M14.34M14.90M13.80M14.23M15.41M15.80M
Gains from Sales and Divestitures 0.08M0.10M0.02M0.04M0.05M0.08M0.01M0.03M0.04M0.04M0.03M0.03M0.04M0.04M0.08M0.16M0.17M0.17M0.15M0.22M0.28M
Gains from Investment Securities 16.32M2.01M1.00M48.83M-0.23M-1.89M1.95M
Asset Writedowns and Impairment 4.92M3.85M
Non-cash Items 7.80M1.27M314.00M1.55M197.00M241.65M246.93M131.55M2.81M49.52M55.93M82.50M75.20M4.57M49.62M109.30M90.90M149.18M97.72M6.56M134.25M7.02M
Cash from Operations -10.80M-12.06M-11.41M131.67M-20.07M-22.82M-30.51M-37.26M-38.35M-40.30M-38.98M-34.27M-39.54M-43.97M-35.26M-31.65M8.04M-39.59M-42.94M-50.19M-61.78M-79.15M-59.88M-27.11M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 1.57M1.28M1.23M1.66M1.64M1.18M0.68M-0.06M-0.91M-1.33M-1.42M-1.22M-1.27M-3.07M-4.02M-3.62M-3.27M-2.52M-2.12M-2.19M
Depreciation & Amortization (CF) 0.20M0.36M0.39M0.39M0.49M0.50M0.48M0.55M0.67M0.69M0.69M0.70M0.77M0.82M0.88M0.90M0.90M0.89M1.46M1.94M1.99M1.99M2.05M2.08M2.15M
Change in Working Capital
Change in Account Payables 1.41M-0.16M-0.21M0.90M0.47M4.15M-0.14M-2.92M-1.03M-1.44M-0.41M4.17M-2.07M2.22M-2.73M1.02M1.53M0.07M0.03M0.09M-0.51M3.92M-4.13M-0.27M
Change in Accured Expenses -0.44M0.69M2.45M-0.87M3.49M0.23M3.86M4.71M3.80M-2.28M0.56M3.40M2.84M-10.04M3.79M2.64M6.79M-15.39M7.80M2.75M9.02M-11.69M4.75M0.66M
Other Working Capital Changes -1.83M-3.43M-3.29M136.04M-11.93M-17.82M-17.63M-18.76M-15.14M-8.36M-9.14M-6.67M-13.60M-6.14M-12.39M-0.95M38.07M-8.26M-23.95M-2.42M-6.45M-2.78M29.20M-2.76M
Investing Activities
Capital Expenditures 0.20M1.40M3.85M2.41M1.44M0.16M0.63M0.31M0.50M0.48M0.73M1.25M0.37M4.01M10.77M8.08M11.62M7.40M4.69M-0.19M0.94M0.47M0.69M0.18M
Change in Acquisitions & Divestments 18.50M65.89M60.50M91.50M109.29M96.88M106.46M147.25M117.67M97.94M90.43M99.25M97.76M76.08M99.50M124.49M138.07M147.93M132.74M118.97M132.44M
Cash from Investing Activities 61.96M-37.40M-46.87M-334.32M-3.99M44.32M60.72M-136.86M-68.02M25.86M81.80M-37.48M-49.67M24.58M35.84M60.51M18.95M-330.61M15.64M-157.68M68.57M48.62M60.02M-235.30M
Financing Activities
Other financing activities 0.12M0.14M0.15M0.11M0.15M0.15M0.19M0.35M0.16M0.26M0.27M0.29M0.30M0.33M0.33M0.34M-0.93M0.29M0.35M0.64M0.29M0.28M0.38M0.42M
Cash from Financing Activities 21.09M93.12M-0.40M196.28M0.27M0.59M1.59M246.04M2.05M0.18M0.36M150.50M1.95M1.16M1.30M-0.21M1.93M353.76M1.41M250.92M2.77M0.26M245.73M39.51M
Additional items
Change in Cash 72.25M43.66M-58.69M-6.38M-23.79M22.09M31.80M71.92M-104.32M-14.25M43.18M78.75M-87.25M-18.23M1.89M28.66M28.93M-16.44M-25.88M43.05M9.55M-30.28M245.86M-222.90M
Beginning Cash Balance 5.34M3.76M77.59M119.66M60.97M54.79M31.00M53.10M84.90M152.29M47.98M33.73M76.91M155.64M68.38M50.50M52.39M81.03M109.95M93.49M67.67M110.71M366.09M89.95M335.85M
Free Cash Flow -11.00M-13.45M-15.27M129.26M-21.50M-22.99M-31.14M-37.57M-38.85M-40.78M-39.72M-35.52M-39.91M-47.98M-46.02M-39.73M-3.58M-46.99M-47.62M-50.00M-62.72M-79.62M-60.58M-27.29M
Net Cash Flow 72.25M43.66M-58.69M-6.38M-23.79M22.09M31.80M71.92M-104.32M-14.25M43.18M78.75M-87.25M-18.23M1.89M28.66M28.93M-16.44M-25.88M43.05M9.55M-30.28M245.86M-222.90M